Antigen Information
General Information of This Antigen
Antigen ID | TAR0NEZUA |
|||||
---|---|---|---|---|---|---|
Antigen Name | Mesothelin (MSLN) |
|||||
Gene Name | MSLN |
|||||
Gene ID | ||||||
Synonym | MPF; CAK1 antigen;Pre-pro-megakaryocyte-potentiating factor |
|||||
Sequence |
MALP.PLLGSCGTPALGSLLFLLFSLGWVQPSRTLAGETGQEAAPLDGVLANPPNISSLS
PRQLLGFPCAEVSGLSTERVRELAVALAQKNVKLSTEQLRCLAHRLSEPPEDLDALPLDL LLFLNPDAFSGPQACTRFFSRITKANVDLLPRGAPERQRLLPAALACWGVRGSLLSEADV RALGGLACDLPGRFVAESAEVLLPRLVSCPGPLDQDQQEAARAALQGGGPPYGPPSTWSV STMDALRGLLPVLGQPIIRSIPQGIVAAWRQRSSRDPSWRQPERTILRPRFRREVEKTAC PSGKKAREIDESLIFYKKWELEACVDAALLATQMDRVNAIPFTYEQLDVLKHKLDELYPQ GYPESVIQHLGYLFLKMSPEDIRKWNVTSLETLKALLEVNKGHEMSPQAPRRPLPQVATL IDRFVKGRGQLDKDTLDTLTAFYPGYLCSLSPEELSSVPPSSIWAVRPQDLDTCDPRQLD VLYPKARLAFQNMNGSEYFVKIQSFLGGAPTEDLKALSQQNVSMDLATFMKLRTDAVLPL TVAEVQKLLGPHVEGLKAEERHRPVRDWILRQRQDDLDTLGLGLQGGIPNGYLVLDLSMQ EALSGTPCLLGPGPVLTVLALLLASTLA Click to Show/Hide
|
|||||
Family | LAMP family |
|||||
Function |
Membrane-anchored forms may play a role in cellular adhesion.; Megakaryocyte-potentiating factor (MPF) potentiates megakaryocyte colony formation in vitro.
Click to Show/Hide
|
|||||
Uniprot Entry | ||||||
HGNC ID | ||||||
KEGG ID |
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
AMA(MMOT0530A)
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
DMOT4039A |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[1] |
Amatuximab
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
MSLN-Mal-PEG2-Val-Cit-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG2-Val-Cit-PABC |
[2] | |
MSLN-Mal-PEG8-Val-Cit-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG8-Val-Cit-PABC |
[2] | |
MSLN-Mal-Caproyl-Val-Cit-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Maleimide-Caproyl-Val-Cit-PABC |
[2] | |
MSLN-Mal-PEG2-Ala-Ala-Asn-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG2-Ala-Ala-Asn-PABC |
[2] | |
MSLN-Mal-PEG4-tria-PEG3-Dis-dim-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG4-triazole-PEG3-Disulfidyl-dimethyl-PABC |
[2] | |
MSLN-Mal-PEG4-tria-PEG3-Sulfo-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG4-triazole-PEG3-Sulfonamide |
[2] | |
MSLN-Mal-PEG2-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG2 |
[2] | |
MSLN-Mal-PEG4-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG4 |
[2] | |
MSLN-Suc/SPAAC-PEG4-Val-Cit-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG4-Val-Cit-PABC |
[2] | |
MSLN-Suc/SPAAC-PEG3-Dis-dim-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG3-Disylfidyl-dimethyl-PABC |
[2] | |
MSLN-Suc/SPAAC-PEG3-Sulfonamide-Eribulin |
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG3-Sulfonamide |
[2] | |
MSLN-Suc/SPAAC-PEG2-Eribulin |
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG2 |
[2] | |
MSLN-Suc/SPAAC-PEG4-Eribulin |
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG4 |
[2] | |
MSLN-Mal-PEG-Val-Cit-PABC-Cryptophycin |
Cryptophycin |
Microtubule (MT) |
Mal-PEG-Val-Cit-PABC |
[2] | |
MSLN-Mal-Caproyl-Val-Cit-PABC-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Maleimide-Caproyl-Val-Cit-PABC |
[2] | |
MSLN-Mal-Caproyl-Val-Cit-PABC-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimide-Caproyl-Val-Cit-PABC |
[2] | |
Amatuximab-Compound 9 |
Mertansine DM1 |
Microtubule (MT) |
Amatuximab-Compound 9 linker |
[3] | |
Amatuximab-Compound 17 |
Mertansine DM4 |
Microtubule (MT) |
Amatuximab-Compound 17 linker |
[3] | |
Amatuximab-Compound 25 |
Monomethyl auristatin E |
Microtubule (MT) |
Amatuximab-Compound 25 linker |
[3] | |
Amatuximab-Compound 31 |
Auristatin 0101 |
Microtubule (MT) |
Amatuximab-Compound 31 linker |
[3] | |
Amatuximab-Compound 36 |
Monomethyl auristatin E |
Microtubule (MT) |
Amatuximab-Compound 36 linker |
[3] | |
Amatuximab-Compound 43 |
PBD dimer |
Human Deoxyribonucleic acid (hDNA) |
Amatuximab-Compound 43 linker |
[3] | |
Amatuximab-Compound 49 |
PBD dimer |
Human Deoxyribonucleic acid (hDNA) |
Amatuximab-Compound 49 linker |
[3] | |
Amatuximab-Compound 55 |
Mertansine DM1 |
Microtubule (MT) |
Amatuximab-Compound 55 linker |
[3] | |
Amatuximab-Compound 59 |
Mertansine DM4 |
Microtubule (MT) |
Amatuximab-Compound 59 linker |
[3] | |
Amatuximab-Compound 64 |
Monomethyl auristatin E |
Microtubule (MT) |
Amatuximab-Compound 64 linker |
[3] | |
Amatuximab-Compound 69 |
Monomethyl auristatin E |
Microtubule (MT) |
Amatuximab-Compound 69 linker |
[3] | |
Amatuximab-Compound 74 |
PBD dimer |
Human Deoxyribonucleic acid (hDNA) |
Amatuximab-Compound 74 linker |
[3] | |
Amatuximab-Compound 75 |
Monomethyl auristatin E |
Microtubule (MT) |
Amatuximab-Compound 75 linker |
[3] | |
Amatuximab-Compound 76 |
Monomethyl auristatin E |
Microtubule (MT) |
Amatuximab-Compound 76 linker |
[3] | |
Amatuximab-Compound 77 |
Mertansine DM1 |
Microtubule (MT) |
Amatuximab-Compound 77 linker |
[3] | |
Amatuximab-Compound 78 |
Auristatin 0101 |
Microtubule (MT) |
Amatuximab-Compound 78 linker |
[3] | |
Amatuximab-Compound 79 |
Auristatin 0101 |
Microtubule (MT) |
Amatuximab-Compound 79 linker |
[3] | |
Amatuximab-Compound 80 |
Mertansine DM4 |
Microtubule (MT) |
Amatuximab-Compound 80 linker |
[3] |
Anetumab
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
Anetumab ravtansine |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[4] | |
Anetumab corixetan |
Undisclosed |
Undisclosed |
Undisclosed |
[5] |
Anti-MSLN Anti-ody Fab fragment
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
RG7787 |
Pseudomonas exotoxin PE24 |
Eukaryotic elongation factor 2 (EEF2) |
Undisclosed |
[6] |
Anti-MSLN IgG1-ALA12
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
ALA12-Val-Cit-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[7] |
Anti-MSLN IgG1-CHS5
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CHS5-Val-Cit-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[7] |
Anti-MSLN IgG1-CHS7
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CHS7-Val-Cit-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[7] |
Anti-MSLN IgG1-CHS8
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CHS8-Val-Cit-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[7] |
Anti-MSLN IgG1-SS1
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
SS1-Val-Cit-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[7] |
Anti-MSLN mAb
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
RC88-PY-MAA-Val-Cit-PAB-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[8] | |
RC88-PY-MAA-Val-Cit-PAB-MMAD |
Monomethyl auristatin D |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[8] | |
RC88-Mc-Val-Cit-PAB-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[8] | |
RC88-Mc-Val-Cit-PAB-MMAD |
Monomethyl auristatin D |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[8] | |
Anti-MSLN-45 ADC |
Tetrahydroisoquinoline-based PBD dimer 17 |
Human Deoxyribonucleic acid (hDNA) |
Mc-Val-Cit-PABC |
[9] | |
Anti-MSLN-46 ADC |
Tetrahydroisoquinoline-based PBD dimer 17 |
Human Deoxyribonucleic acid (hDNA) |
PEG2-Val-Cit-PABC |
[9] | |
Anti-MSLN-47 ADC |
Tetrahydroisoquinoline-based PBD dimer 17 |
Human Deoxyribonucleic acid (hDNA) |
PEG4-Val-Cit-PABC |
[9] | |
Anti-MSLN-48 ADC |
Tetrahydroisoquinoline-based PBD dimer 17 |
Human Deoxyribonucleic acid (hDNA) |
PEG8-Val-Cit-PABC |
[9] | |
Anti-MSLN-44 ADC |
Tetrahydroisoquinoline-based PBD dimer 14 |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG8-Val-Cit-PABC |
[9] |
Anti-MSLN mAb 6A4
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
Anti-MSLN mAb 6A4-IIIa-01 |
Anti-MSLN mAb 6A4-IIIa-01 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIa-01 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIa-02 |
Anti-MSLN mAb 6A4-IIIa-02 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIa-02 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIa-03 |
Anti-MSLN mAb 6A4-IIIa-03 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIa-03 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIa-04 |
Anti-MSLN mAb 6A4-IIIa-04 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIa-04 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIa-05 |
Anti-MSLN mAb 6A4-IIIa-05 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIa-05 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIa-06 |
Anti-MSLN mAb 6A4-IIIa-06 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIa-06 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIa-07 |
Anti-MSLN mAb 6A4-IIIa-07 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIa-07 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIa-08 |
Anti-MSLN mAb 6A4-IIIa-08 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIa-08 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIb-01 |
Anti-MSLN mAb 6A4-IIIb-01 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIb-01 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIb-02 |
Anti-MSLN mAb 6A4-IIIb-02 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIb-02 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIb-03 |
Anti-MSLN mAb 6A4-IIIb-03 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIb-03 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIb-04 |
Anti-MSLN mAb 6A4-IIIb-04 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIb-04 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIb-05 |
Anti-MSLN mAb 6A4-IIIb-05 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIb-05 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIb-06 |
Anti-MSLN mAb 6A4-IIIb-06 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIb-06 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIb-07 |
Anti-MSLN mAb 6A4-IIIb-07 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIb-07 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIb-08 |
Anti-MSLN mAb 6A4-IIIb-08 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIb-08 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIb-09 |
Anti-MSLN mAb 6A4-IIIb-09 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIb-09 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIc-01 |
Anti-MSLN mAb 6A4-IIIc-01 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIc-01 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIc-02 |
Anti-MSLN mAb 6A4-IIIc-02 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIc-02 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIc-03 |
Anti-MSLN mAb 6A4-IIIc-03 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIc-03 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIc-04 |
Anti-MSLN mAb 6A4-IIIc-04 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIc-04 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIc-05 |
Anti-MSLN mAb 6A4-IIIc-05 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIc-05 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIc-06 |
Anti-MSLN mAb 6A4-IIIc-06 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIc-06 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIc-07 |
Anti-MSLN mAb 6A4-IIIc-07 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIc-07 linker |
[10] | |
Anti-MSLN mAb 6A4-IIIc-08 |
Anti-MSLN mAb 6A4-IIIc-08 payload |
Undisclosed |
Anti-MSLN mAb 6A4-IIIc-08 linker |
[10] | |
Anti-MSLN mAb 6A4-A |
Anti-MSLN mAb 6A4-A payload |
Undisclosed |
Anti-MSLN mAb 6A4 linker |
[10] |
Anti-MSLN scFv
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
LMB-100 |
Pseudomonas exotoxin LO10R456A |
Eukaryotic elongation factor 2 (EEF2) |
Undisclosed |
[11] | |
LMB-12 |
Pseudomonas exotoxin PE24 |
Eukaryotic elongation factor 2 (EEF2) |
Undisclosed |
[11] | |
LMB-164 |
Pseudomonas exotoxin PE24 |
Eukaryotic elongation factor 2 (EEF2) |
Undisclosed |
[11] |
BMS-986021
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
BMS-986148 |
Tubulysin |
Microtubule (MT) |
Mal-EBE-Mal |
[12] |
Humanized IgG1 Anti-MSLN mAb h7D9.v3
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
RG-7600 |
Monomethyl auristatin E |
Microtubule (MT) |
Protease-labile valine-citrulline linker |
[13] |
Undisclosed
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
RC-88 |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[14] | |
HBM9033 |
Undisclosed |
Undisclosed |
Undisclosed |
[15] | |
Anti-mesothelin antibody-drug conjugate (Bristol Myers Squibb) |
Undisclosed |
Undisclosed |
Undisclosed |
[16] | |
MSLN ADC (Development Center for Biotechnology) |
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
[17] | |
MSLN MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
[18] | |
NAV-001 |
Undisclosed |
Undisclosed |
Undisclosed |
[19] | |
LCB14-17nn |
Undisclosed |
Undisclosed |
Undisclosed |
[20] | |
Immunoconjugate (Bayer AG) |
Undisclosed |
Undisclosed |
Undisclosed |
[21] |
Tissue/Disease specific Abundances of This Antigen
Tissue specific Abundances of This Antigen
ICD Disease Classification 01
Bacterial infection [ICD-11: 1A00-1C4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gingival | |
The Specific Disease | Bacterial infection of gingival | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.028791747; Fold-change: 0.137609449; Z-score: 0.468098562 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 02
Brain cancer [ICD-11: 2A00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Brainstem | |
The Specific Disease | Glioma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.253486974; Fold-change: -0.278509499; Z-score: -2.639844984 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | White matter | |
The Specific Disease | Glioma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 3.45E-11; Fold-change: -0.997746164; Z-score: -6.480465887 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Brainstem | |
The Specific Disease | Neuroectodermal tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.568055386; Fold-change: -0.077386828; Z-score: -0.29408118 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Nervous | |
The Specific Disease | Brain cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 2.39E-11; Fold-change: -0.183965444; Z-score: -0.740215905 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic myeloid leukemia [ICD-11: 2A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Polycythemia vera | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 3.78E-05; Fold-change: 0.155482803; Z-score: 1.057877693 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Whole blood | |
The Specific Disease | Myelofibrosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.031530062; Fold-change: 0.10058837; Z-score: 0.611572362 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
MyeloDysplastic syndromes [ICD-11: 2A37]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Myelodysplastic syndromes | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.361411125; Fold-change: 0.08405356; Z-score: 0.39615733 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.060861092; Fold-change: -0.397621123; Z-score: -1.606712428 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lymphoma [ICD-11: 2A90- 2A85]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Tonsil | |
The Specific Disease | Lymphoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.184624787; Fold-change: 0.125464387; Z-score: 0.884019347 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Gastric cancer [ICD-11: 2B72]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gastric | |
The Specific Disease | Gastric cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000265201; Fold-change: 2.07020139; Z-score: 9.519314426 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 3.72E-07; Fold-change: 2.197423049; Z-score: 2.181182738 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Colon cancer [ICD-11: 2B90]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Colon | |
The Specific Disease | Colon cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 4.65E-58; Fold-change: 0.745180594; Z-score: 1.311687493 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 5.05E-51; Fold-change: 0.718030452; Z-score: 1.316576668 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pancreatic cancer [ICD-11: 2C10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pancreas | |
The Specific Disease | Pancreatic cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 2.86E-20; Fold-change: 3.97890685; Z-score: 6.120864756 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 6.78E-36; Fold-change: 3.162585573; Z-score: 4.125456732 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Liver cancer [ICD-11: 2C12]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Liver cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.605118057; Fold-change: -0.202510155; Z-score: -0.666597206 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.024483322; Fold-change: 0.011764448; Z-score: 0.044658738 | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.164537402; Fold-change: 0.016814715; Z-score: 0.109329282 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lung cancer [ICD-11: 2C25]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Lung cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 3.48E-29; Fold-change: -1.697558326; Z-score: -1.376934975 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 8.37E-22; Fold-change: -1.946326424; Z-score: -1.565440602 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Melanoma [ICD-11: 2C30]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Melanoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.002700919; Fold-change: -0.554833188; Z-score: -0.95895814 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sarcoma [ICD-11: 2C35]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Sarcoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.088480623; Fold-change: -0.085809746; Z-score: -0.327206225 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.036301808; Fold-change: 0.120794782; Z-score: 0.656558082 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Breast cancer [ICD-11: 2C60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Breast | |
The Specific Disease | Breast cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.13E-22; Fold-change: 0.073109659; Z-score: 0.16710702 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.75E-14; Fold-change: 0.058703642; Z-score: 0.19212618 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ovarian cancer [ICD-11: 2C73]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Ovarian | |
The Specific Disease | Ovarian cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.013548348; Fold-change: 5.443607931; Z-score: 1.915568501 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.018770436; Fold-change: 2.102347412; Z-score: 0.841257334 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Cervical cancer [ICD-11: 2C77]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Cervical | |
The Specific Disease | Cervical cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.220110551; Fold-change: 1.393902181; Z-score: 0.623502276 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Uterine cancer [ICD-11: 2C78]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Endometrium | |
The Specific Disease | Uterine cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.26715813; Fold-change: -0.353642985; Z-score: -0.242373675 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 3.35E-07; Fold-change: 0.768370784; Z-score: 2.763706836 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Prostate cancer [ICD-11: 2C82]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Prostate | |
The Specific Disease | Prostate cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.507206577; Fold-change: 0.170131292; Z-score: 0.227543567 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Bladder cancer [ICD-11: 2C94]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bladder | |
The Specific Disease | Bladder cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000145816; Fold-change: 0.160014184; Z-score: 0.838968259 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Retina cancer [ICD-11: 2D02]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Uvea | |
The Specific Disease | Retinoblastoma tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.514741921; Fold-change: -0.046095382; Z-score: -0.254131984 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Thyroid cancer [ICD-11: 2D10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Thyroid | |
The Specific Disease | Thyroid cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.003517292; Fold-change: 0.024734579; Z-score: 0.136833138 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.018954495; Fold-change: 0.058674238; Z-score: 0.276828341 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Adrenal cancer [ICD-11: 2D11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Adrenal cortex | |
The Specific Disease | Adrenocortical carcinoma | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.290165106; Fold-change: -0.10775474; Z-score: -0.547917444 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Head and neck cancer [ICD-11: 2D42]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Head and neck | |
The Specific Disease | Head and neck cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 3.62E-15; Fold-change: -2.414171723; Z-score: -1.098492184 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pituitary cancer [ICD-11: 2F37]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pituitary | |
The Specific Disease | Pituitary gonadotrope tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.560621316; Fold-change: -0.13083818; Z-score: -0.669670627 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Pituitary | |
The Specific Disease | Pituitary cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.96456975; Fold-change: -0.077464853; Z-score: -0.297087373 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 03
Thrombocytopenia [ICD-11: 3B64]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Thrombocytopenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.27532534; Fold-change: 0.265292493; Z-score: 0.780055102 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 04
Lupus erythematosus [ICD-11: 4A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Lupus erythematosus | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.298563364; Fold-change: -0.022694835; Z-score: -0.066567709 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Autoimmune disease [ICD-11: 4A4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral monocyte | |
The Specific Disease | Autoimmune uveitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.040294787; Fold-change: -0.236144868; Z-score: -1.830617537 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 05
Hyperlipoproteinaemia [ICD-11: 5C80]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Familial hypercholesterolemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.55917858; Fold-change: -0.029365838; Z-score: -0.130608906 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 06
Schizophrenia [ICD-11: 6A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Superior temporal cortex | |
The Specific Disease | Schizophrenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.918068319; Fold-change: -0.04469937; Z-score: -0.343927434 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 08
Multiple sclerosis [ICD-11: 8A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Spinal cord | |
The Specific Disease | Multiple sclerosis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.467449613; Fold-change: -0.104378177; Z-score: -0.551079956 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Plasmacytoid dendritic cells | |
The Specific Disease | Multiple sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.117568268; Fold-change: 0.316706507; Z-score: 0.934427897 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Epilepsy [ICD-11: 8A60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peritumoral cortex | |
The Specific Disease | Epilepsy | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.613438353; Fold-change: 0.243515582; Z-score: 3.251366033 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Cerebral ischaemic stroke [ICD-11: 8B11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Cardioembolic Stroke | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.655526801; Fold-change: 0.069714557; Z-score: 0.275649336 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Peripheral blood | |
The Specific Disease | Ischemic stroke | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.505247889; Fold-change: -0.079783632; Z-score: -0.690500104 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 1
HIV [ICD-11: 1C60-1C62]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | White matter | |
The Specific Disease | HIV | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.094336587; Fold-change: 0.068617695; Z-score: 0.356317114 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Influenza [ICD-11: 1E30]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Influenza | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.47939932; Fold-change: 0.047120672; Z-score: 0.275992784 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic hepatitis C [ICD-11: 1E51.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Chronic hepatitis C | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.585763912; Fold-change: -0.029136193; Z-score: -0.13820537 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sepsis [ICD-11: 1G40-1G41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Sepsis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.319027272; Fold-change: -0.011612671; Z-score: -0.047463985 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Septic shock [ICD-11: 1G41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Septic shock | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.214983863; Fold-change: -0.062086515; Z-score: -0.245339078 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pediatric respiratory syncytial virus infection [ICD-11: CA40.11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Pediatric respiratory syncytial virus infection | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.676199148; Fold-change: -0.013871187; Z-score: -0.096139742 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 11
Essential hypertension [ICD-11: BA00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Essential hypertension | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.783280908; Fold-change: 0.010880365; Z-score: 0.068089911 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myocardial infarction [ICD-11: BA41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Myocardial infarction | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.047374834; Fold-change: 0.104891162; Z-score: 0.33810991 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Coronary artery disease [ICD-11: BA8Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Coronary artery disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.649511487; Fold-change: -0.108773107; Z-score: -0.375852568 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Aortic stenosis [ICD-11: BB70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Calcified aortic valve | |
The Specific Disease | Aortic stenosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.603180611; Fold-change: 0.054025384; Z-score: 0.175864811 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arteriosclerosis [ICD-11: BD40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arteriosclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.584961139; Fold-change: 0.046546553; Z-score: 0.245142768 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Aneurysm [ICD-11: BD50]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Intracranial artery | |
The Specific Disease | Aneurysm | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.176859871; Fold-change: 0.073464705; Z-score: 0.448752615 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 12
Immunodeficiency [ICD-11: 4A00-4A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Immunodeficiency | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.380492677; Fold-change: 0.019962981; Z-score: 0.174932536 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Apnea [ICD-11: 7A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Hyperplastic tonsil | |
The Specific Disease | Apnea | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.278619097; Fold-change: 0.830953345; Z-score: 5.321845094 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Olive pollen allergy [ICD-11: CA08.00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Olive pollen allergy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.147128656; Fold-change: 0.041379305; Z-score: 0.406026168 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic rhinosinusitis [ICD-11: CA0A]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Sinus mucosa | |
The Specific Disease | Chronic rhinosinusitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.965788338; Fold-change: -0.260780923; Z-score: -0.182204862 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic obstructive pulmonary disease [ICD-11: CA22]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Chronic obstructive pulmonary disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.091052947; Fold-change: -0.433029234; Z-score: -0.333605282 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Small airway epithelium | |
The Specific Disease | Chronic obstructive pulmonary disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.990735514; Fold-change: 0.286578141; Z-score: 0.215509214 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Asthma [ICD-11: CA23]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Nasal and bronchial airway | |
The Specific Disease | Asthma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.137035517; Fold-change: 0.185783188; Z-score: 0.132394904 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Human rhinovirus infection [ICD-11: CA42]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Nasal Epithelium | |
The Specific Disease | Human rhinovirus infection | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.635900973; Fold-change: -0.143318263; Z-score: -0.237727936 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Idiopathic pulmonary fibrosis [ICD-11: CB03.4]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Idiopathic pulmonary fibrosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.003107136; Fold-change: 1.676241486; Z-score: 2.703852349 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 13
Periodontal disease [ICD-11: DA0C]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gingival | |
The Specific Disease | Periodontal disease | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.048553793; Fold-change: 0.110263309; Z-score: 0.404921769 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Eosinophilic gastritis [ICD-11: DA42.2]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gastric antrum | |
The Specific Disease | Eosinophilic gastritis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.454322832; Fold-change: -0.013261356; Z-score: -0.118656796 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Liver failure [ICD-11: DB99.7-DB99.8]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Liver failure | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.18614918; Fold-change: -0.105774339; Z-score: -0.271947492 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ulcerative colitis [ICD-11: DD71]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Colon mucosal | |
The Specific Disease | Ulcerative colitis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.305823353; Fold-change: 0.191196643; Z-score: 0.596807587 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Irritable bowel syndrome [ICD-11: DD91.0]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Rectal colon | |
The Specific Disease | Irritable bowel syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.410532846; Fold-change: 0.025060293; Z-score: 0.07054369 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 14
Atopic dermatitis [ICD-11: EA80]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Atopic dermatitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 9.71E-05; Fold-change: 0.175221004; Z-score: 1.268113691 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Psoriasis [ICD-11: EA90]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Psoriasis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.196374003; Fold-change: -0.003850252; Z-score: -0.0094188 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 2.59E-05; Fold-change: -0.151675304; Z-score: -0.448426118 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Vitiligo [ICD-11: ED63.0]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Vitiligo | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.860036326; Fold-change: 0.02315172; Z-score: 0.095139616 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Alopecia [ICD-11: ED70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin from scalp | |
The Specific Disease | Alopecia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.912487479; Fold-change: 0.014103226; Z-score: 0.059648153 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sensitive skin [ICD-11: EK0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Sensitive skin | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.913634937; Fold-change: 0.024342822; Z-score: 0.157811159 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 15
Osteoarthritis [ICD-11: FA00-FA0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Synovial | |
The Specific Disease | Osteoarthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.749253139; Fold-change: -0.200350163; Z-score: -0.395088622 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arthropathy [ICD-11: FA00-FA5Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arthropathy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.446436085; Fold-change: -0.002701082; Z-score: -0.021767533 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arthritis [ICD-11: FA20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 4.38E-05; Fold-change: 0.079271089; Z-score: 0.319655527 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Rheumatoid arthritis [ICD-11: FA20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Synovial | |
The Specific Disease | Rheumatoid arthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.108776; Fold-change: -0.338163994; Z-score: -1.282439225 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ankylosing spondylitis [ICD-11: FA92.0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pheripheral blood | |
The Specific Disease | Ankylosing spondylitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.838603737; Fold-change: -0.001925132; Z-score: -0.015415255 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Osteoporosis [ICD-11: FB83]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Osteoporosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.628025469; Fold-change: 0.153831424; Z-score: 0.428651689 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 16
Endometriosis [ICD-11: GA10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Endometrium | |
The Specific Disease | Endometriosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.062634408; Fold-change: 0.184347412; Z-score: 0.292205397 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Interstitial cystitis [ICD-11: GC00.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bladder | |
The Specific Disease | Interstitial cystitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.222952356; Fold-change: 0.05325689; Z-score: 0.881447821 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 19
Preterm birth [ICD-11: KA21.4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Myometrium | |
The Specific Disease | Preterm birth | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.7372469; Fold-change: 0.143868749; Z-score: 0.099091107 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 2
Acute myelocytic leukemia [ICD-11: 2A60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Acute myelocytic leukemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 4.52E-09; Fold-change: 0.132726945; Z-score: 0.59304189 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myeloma [ICD-11: 2A83]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Myeloma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.004431988; Fold-change: -0.391569247; Z-score: -1.310241772 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Peripheral blood | |
The Specific Disease | Myeloma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.128624415; Fold-change: -0.118632599; Z-score: -0.554655577 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Oral cancer [ICD-11: 2B6E]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Oral | |
The Specific Disease | Oral cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.309380496; Fold-change: 0.006242078; Z-score: 0.010065549 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.53E-12; Fold-change: 0.336370784; Z-score: 1.047380083 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Esophagal cancer [ICD-11: 2B70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Esophagus | |
The Specific Disease | Esophagal cancer | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.255151027; Fold-change: -0.181165053; Z-score: -0.316546046 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Rectal cancer [ICD-11: 2B92]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Rectal colon | |
The Specific Disease | Rectal cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000949688; Fold-change: 0.416914156; Z-score: 1.001155526 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.88E-05; Fold-change: 0.601401835; Z-score: 1.982361683 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Skin cancer [ICD-11: 2C30-2C3Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Skin cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 5.63E-10; Fold-change: -0.310189191; Z-score: -0.707671231 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.52E-12; Fold-change: -0.34205169; Z-score: -0.839058923 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Renal cancer [ICD-11: 2C90-2C91]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Kidney | |
The Specific Disease | Renal cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.034707552; Fold-change: -0.126523737; Z-score: -0.315635257 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.065149175; Fold-change: -0.146396741; Z-score: -0.23880053 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ureter cancer [ICD-11: 2C92]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Urothelium | |
The Specific Disease | Ureter cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.978924572; Fold-change: -0.055702624; Z-score: -0.213040725 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 20
Simpson golabi behmel syndrome [ICD-11: LD2C]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Adipose | |
The Specific Disease | Simpson golabi behmel syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.619475009; Fold-change: -0.106855456; Z-score: -0.775748627 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Tuberous sclerosis complex [ICD-11: LD2D.2]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Perituberal | |
The Specific Disease | Tuberous sclerosis complex | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.515913762; Fold-change: -0.026626251; Z-score: -0.221043017 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 3
Anemia [ICD-11: 3A00-3A9Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Anemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.240059153; Fold-change: -0.090717835; Z-score: -0.410846491 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sickle cell disease [ICD-11: 3A51.0-3A51.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Sickle cell disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.481679843; Fold-change: 0.110643829; Z-score: 0.429755239 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Thrombocythemia [ICD-11: 3B63]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Thrombocythemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000182263; Fold-change: 0.13704235; Z-score: 0.880654144 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 4
Scleroderma [ICD-11: 4A42.Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Scleroderma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.879212721; Fold-change: -0.121629601; Z-score: -0.717297757 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sjogren syndrome [ICD-11: 4A43]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Salivary gland | |
The Specific Disease | Sjogren syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.66073022; Fold-change: -0.131941889; Z-score: -0.110396051 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.062879566; Fold-change: -3.749512853; Z-score: -1.722822802 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Behcet disease [ICD-11: 4A62]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Behcet disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.062114; Fold-change: 0.096950731; Z-score: 1.015889268 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Autosomal dominant monocytopenia [ICD-11: 4B04]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Autosomal dominant monocytopenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.999225203; Fold-change: 0.03692002; Z-score: 0.213341499 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 5
Type 2 diabetes [ICD-11: 5A11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Type 2 diabetes | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.731786188; Fold-change: 0.029136621; Z-score: 0.205505189 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Polycystic ovary syndrome [ICD-11: 5A80.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Vastus lateralis muscle | |
The Specific Disease | Polycystic ovary syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.334153589; Fold-change: 0.061882464; Z-score: 0.236513104 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Obesity [ICD-11: 5B81]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Subcutaneous Adipose | |
The Specific Disease | Obesity | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.266199961; Fold-change: -0.037600986; Z-score: -0.182389964 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pompe disease [ICD-11: 5C51.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Biceps muscle | |
The Specific Disease | Pompe disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.292300891; Fold-change: 0.001524674; Z-score: 0.014009575 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Batten disease [ICD-11: 5C56.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Batten disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.712486366; Fold-change: -0.011123979; Z-score: -0.076843548 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 6
Autism [ICD-11: 6A02]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Autism | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.949263894; Fold-change: 0.040032546; Z-score: 0.152870562 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Anxiety disorder [ICD-11: 6B00-6B0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Anxiety disorder | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.189176975; Fold-change: 0.039092829; Z-score: 0.114930722 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 8
Parkinson disease [ICD-11: 8A00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Substantia nigra | |
The Specific Disease | Parkinson disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.543524833; Fold-change: 0.008445879; Z-score: 0.050232166 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Huntington disease [ICD-11: 8A01]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Huntington disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.048701734; Fold-change: 0.249532734; Z-score: 1.344682573 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Alzheimer disease [ICD-11: 8A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Entorhinal cortex | |
The Specific Disease | Alzheimer disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.663149939; Fold-change: -0.005982565; Z-score: -0.031019523 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Seizure [ICD-11: 8A60-8A6Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Seizure | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.845834994; Fold-change: 0.045517429; Z-score: 0.26726406 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lateral sclerosis [ICD-11: 8B60.4]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Lateral sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.320461741; Fold-change: -0.039026508; Z-score: -0.363586987 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Cervical spinal cord | |
The Specific Disease | Lateral sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.415240606; Fold-change: 0.010761097; Z-score: 0.111639232 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Muscular atrophy [ICD-11: 8C70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Muscular atrophy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.002577916; Fold-change: -0.276488762; Z-score: -1.145909533 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myopathy [ICD-11: 8C70.6]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Myopathy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.208695316; Fold-change: -0.065774401; Z-score: -0.416859137 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.